Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Silverstein

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Blood|December 10, 1999
Stromal derived factor-1-induced chemokinesis of cord blood CD34(+) cells (long-term culture-initiating cells) through endothelial cells is mediated by E-selectinA J Naiyer, D Y Jo, J Ahn, et al.
The Journal of Clinical Investigation|April 20, 2000
Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in miceM Febbraio, E A Podrez, J D Smith, et al.
Circulation Research|May 4, 2002
CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heartV Bodart, M Febbraio, A Demers, et al.
Blood|February 15, 1994
CD antigens 1993S F Schlossman, L Boumsell, W Gilks, et al.
Immunology Today|March 1, 1994
CD antigens 1993S F Schlossman, L Boumsell, W Gilks, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1994
CD antigens 1993S F Schlossman, L Boumsell, W Gilks, et al.
Experimental Cell Research|May 18, 1999
Retinoic acid alters the mechanism of attachment of malignant astrocytoma and neuroblastoma cells to thrombospondin-1V Pijuan-Thompson, J R Grammer, J Stewart, et al.
International Journal of Laboratory Hematology|May 12, 2012
P2RY1 and P2RY12 polymorphisms and on-aspirin platelet reactivity in patients with coronary artery diseaseA A Timur, G Murugesan, L Zhang, et al.
The Journal of Clinical Investigation|April 20, 2000
Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen speciesE A Podrez, M Febbraio, N Sheibani, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1995
Principles of thromboregulation: control of platelet reactivity in vascular diseaseA J Marcus, L B Safier, W E Kaminski, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Blood|December 10, 1999
Stromal derived factor-1-induced chemokinesis of cord blood CD34(+) cells (long-term culture-initiating cells) through endothelial cells is mediated by E-selectinA J Naiyer, D Y Jo, J Ahn, et al.
The Journal of Clinical Investigation|April 20, 2000
Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in miceM Febbraio, E A Podrez, J D Smith, et al.
Circulation Research|May 4, 2002
CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heartV Bodart, M Febbraio, A Demers, et al.
Blood|February 15, 1994
CD antigens 1993S F Schlossman, L Boumsell, W Gilks, et al.
Immunology Today|March 1, 1994
CD antigens 1993S F Schlossman, L Boumsell, W Gilks, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1994
CD antigens 1993S F Schlossman, L Boumsell, W Gilks, et al.
Experimental Cell Research|May 18, 1999
Retinoic acid alters the mechanism of attachment of malignant astrocytoma and neuroblastoma cells to thrombospondin-1V Pijuan-Thompson, J R Grammer, J Stewart, et al.
International Journal of Laboratory Hematology|May 12, 2012
P2RY1 and P2RY12 polymorphisms and on-aspirin platelet reactivity in patients with coronary artery diseaseA A Timur, G Murugesan, L Zhang, et al.
The Journal of Clinical Investigation|April 20, 2000
Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen speciesE A Podrez, M Febbraio, N Sheibani, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1995
Principles of thromboregulation: control of platelet reactivity in vascular diseaseA J Marcus, L B Safier, W E Kaminski, et al.
Pageof 8